| mRNA |
681640 |
GDSC1000 |
pan-cancer |
AAC |
-0.0024 |
0.9 |
| mRNA |
WAY-362450 |
CTRPv2 |
pan-cancer |
AAC |
-0.0024 |
1 |
| mRNA |
BRD-K27188169 |
CTRPv2 |
pan-cancer |
AAC |
0.0033 |
1 |
| mRNA |
fulvestrant |
CTRPv2 |
pan-cancer |
AAC |
0.0046 |
1 |
| mRNA |
BRD-A02303741 |
CTRPv2 |
pan-cancer |
AAC |
0.0022 |
1 |
| mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0019 |
1 |
| mRNA |
navitoclax:pluripotin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0021 |
1 |
| mRNA |
QS11 |
GDSC1000 |
pan-cancer |
AAC |
0.002 |
1 |
| mRNA |
trifluoperazine |
CTRPv2 |
pan-cancer |
AAC |
0.0022 |
1 |
| mRNA |
BRD-K02251932 |
CTRPv2 |
pan-cancer |
AAC |
0.0021 |
1 |